Browse EX-10 agreements

STOCKHOLDER AGREEMENT OF
QUANTINUUM INC.

THIS STOCKHOLDER AGREEMENT, dated as of June 3, 2026 (as it may be amended, amended and restated or otherwise modified from time to time in accordance with the terms hereof, this “Agreement”), is entered into by and between Quantinuum Inc., a Delaware corporation (the “Corporation”), and Honeywell International Inc., a Delaware corporation (“Honeywell”), each of which may be referred to in this Agreement as a “party” and together as the “parties.” Certain terms used in this Agreement are defined in Section 7.

RECITALS

WHEREAS, the Corporation is effecting an underwritten initial public offering (“IPO”) of shares of its Class A Common Stock (as defined below);

WHEREAS, the parties hereto desire to enter into this Agreement to govern certain of their rights, duties and obligations with respect to the governance of the Corporation after the Closing (as defined below); and

WHEREAS, it is understood and acknowledged that none of the obligations and rights contained in this Agreement must become effective until the Closing.

…

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT(this “Agreement”), is made as of June 3, 2026, by and among Quantinuum Inc., (the “Company”), Cambridge Quantum Holdings Limited, Colorado Holdco, Honeywell Holdings International Inc., Honeywell International Inc., JPMC Strategic Investments I Corporation, Mitsui & Co., Ltd., NVentures LLC, and Quanta Computer Inc., each of which may be referred to in this Agreement as a “Party” and together as the “Parties.”

RECITALS:

WHEREAS, the Company is effecting an underwritten initial public offering (“IPO”) of shares of its Class A common stock, par value $0.0001 per share (the “Class A Common Stock” or the “Class A Shares” and, holders of Class A Common Stock or Class A Shares, the “Shareholders”);

…

DEFI DEVELOPMENT CORP.

CONSULTING AGREEMENT

This Consulting Agreement (this “Agreement”) is made on 8/10/2026 and shall have effect as of June 8, 2026 (the “Effective Date”), by and between DeFi Development Corp., a Delaware corporation (the “Company”), and Mempool Exploration, LLC (“Consultant”).

1.Consulting Relationship.During the term of this Agreement, Consultant will provide consulting services to the Company regarding transition of operations of certain validators owned by the Company and related matters (the “Services”), including providing the Company with a written transition plan for operations of the Company’s validators within 6 weeks after the EffectiveDate. Consultant will use Consultant’s best efforts to perform the Services such that the results are satisfactory to the Company.

…

May 15, 2026

Svai Sanford

VIA DOCUSIGN/EMAIL

Dear Svai:

This letter sets forth the terms of the mutual separation agreement (the “Agreement”) between you and Rani Therapeutics Holdings, Inc. (the “Company”), reflecting the parties’ shared decision to transition your employment relationship and facilitate an orderly transfer of your responsibilities to your successor.

1.

SEPARATION. Your last day of work with the Company and your employment termination date will be a date to be determined by you and the Company (the “Separation Date”). The intent is for the Company to identify your successor in the near term and for you to overlap with that person for some period of time once he/she commences employment with the Company. The Company will provide you with written notice of the Separation Date as soon as reasonably practicable following the identification of your successor and the establishment of his/her first day of employment with the Company. Regardless of when the Separation Date occurs, the Company will continue to pay you your base salary at the rate now in effect through

…

ETON PHARMACEUTICALS, INC.

21925 W. Field Parkway, Suite 235

Deer Park, IL 60010-7278

March 31, 2026 (amended June 1, 2026 for change in severance provision)

Judith Matthews

Re:         Employment Terms

Dear Judith:

On behalf of Eton Pharmaceuticals, Inc. (the “Company”), I am pleased to offer you employment in the position of Executive Vice President, Finance, of the Company, on the terms set forth in this offer letter agreement (the “Agreement”). The Company and the Board of Directors (the “Board”) have identified you as the designated successor to the role of Chief Financial Officer as part of the Company’s executive leadership succession planning. It is the Company’s current expectation that you will be appointed to serve as Chief Financial Officer by June 1st, 2026.

…

Certain information has been excluded from the exhibit because it is both not material and is the type that the registrant treats as private or confidential

SUPPLY AND DISTRIBUTION AGREEMENT

- by and between -

KNIGHT THERAPEUTICS EUROPE S.A.

- and -

ETON PHARMACEUTICALS, INC.

May 18, 2026

---

TABLE OF CONTENTS

Article 1 DEFINITIONS AND CONSTRUCTION		2
1.1	Definitions.	2

…

***SIXTH AMENDMENT TO ***

CREDIT AGREEMENT

THIS SIXTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of April 9, 2026, is entered into by and among ETON PHARMACEUTICALS, INC., a Delaware corporation (“Borrower”), each of the undersigned financial institutions (individually each a “Lender” and collectively “Lenders”), SWK FUNDING LLC, a Delaware limited liability company, in its capacity as administrative agent for the Lenders (in such capacity, “Agent”).

RECITALS

WHEREAS, Borrower, Agent and Lenders entered into that certain Credit Agreement dated as of November 13, 2019 (as the same may be amended, modified or restated from time to time, being hereinafter referred to as the “Credit Agreement”); and

WHEREAS, Borrower, Agent and Lenders desire to amend the Credit Agreement as set forth herein.

AGREEMENT

…

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.

ANNUAL PURCHASE CONTRACT

Contract No.: CSLA[***]

**Party A (Buyer): **Nanjing Casela Technologies Corporation Limited

**Contact Address: **9th Floor, Building C, Optoelectronics Technology Park, No. 6 Yuhe Road, Jiangbei New Area, Nanjing, China

**Contact Person: **[***] Telephone: [***]

**Party B (Supplier): **Beijing Tongmei Xtal Technology Co., Ltd.

**Contact Address: **No. 4 East Second Street, Tongmei Industrial Development Zone, Beijing, China

**Contact Person: **Li Kai Telephone:[***]

WHEREAS:

1. In light of its production and operational requirements, Party A intends to lock in long-term supply quantities with Party B so as to secure a stable source of supply and priority of supply.

…

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.

Master Development and Supply Agreement

AXT 6-inch InP

This Master Development and Supply Agreement (this “Agreement”) is entered into, effective as of June 25, 2026 (the “Effective Date”), by and between AXT-Tongmei, Inc., a Delaware Corporation having its principal place of business at 4281 Technology Drive, Fremont, California, 94538, on behalf of itself and its Affiliates (collectively, “AXT”), and Coherent Corp., a Pennsylvania Corporation having its principal place of business at 375 Saxonburg Blvd., Saxonburg, PA 16056, on behalf of itself and its Affiliates (collectively, “Coherent”).

Each of AXT and Coherent may be referred to herein individually as a “Party” and collectively as the “Parties.”

…

THIS SUBLEASE AGREEMENT (“Sublease”) is entered and effective this 29th

day of April, 20, 2026 , by

Marchex, Inc., a(n) Delaware corporation(“Tenant” OR "MARCHEX"), and RentSpree, Inc. , a(n)

a Delaware corporation(“SUBTENANT” OR "RENTSPREE"). (“Subtenant”). Tenant entered into that certain leaseagreement dated MARCHEX ENTERED INTO THAT CERTAIN SUBLEASE AGREEMENT DATED DECEMBER 20, 2022 (THE “EXISTING SUBLEASE”) WITH NELSON WORLDWIDE, LLC, A PENNSYLVANIA LIMITED LIABILITY COMPANY (“LANDLORD”

…

SETTLEMENT AGREEMENT

This Settlement Agreement and Mutual Release (the "Agreement") is entered into as of April 14, 2026 (the "Effective Date"), by and among:

Chris Barnard and Sine McEvenue, solely in their capacity as the Shareholder Representatives for the former shareholders of Telmetrics Inc. (collectively, the "Shareholder Representatives" or "Plaintiffs"), Chris Barnard (in his personal capacity), Sine McEvenue (in his personal capacity), Andrew Osmak, and Richard Zurawski, on the one hand, and Marchex, Inc., a Delaware corporation ("Marchex" or "Defendant") and Telmetrics Corp., on the other hand. Plaintiffs and Defendant may be referred to individually as a "Party" and collectively as the "Parties."

RECITALS

WHEREAS, on November 5, 2018, Marchex acquired Telmetrics Inc. pursuant to a Share Purchase Agreement (the "SPA");

…

SETTLEMENT AGREEMENT

This Settlement Agreement (this ***"Settlement ******Agreement") is entered into between and among Navigation Powder River, LLC ("Plaintiff') ***and Phoenix Energy One, LLC ***("Defe11da11t"; ***Defendant and Plaintiff each individually a ***"Party" ***and collectively, the ***"Parties"). ***This Settlement Agreement shall be deemed executed as of the date of the latest Party's signature (the *"Effective *Date").

RECITALS

**WHEREAS, **on September I 0, 2025, Plaintiff initiated a lawsuit against Defendant in the Texas Business Court, 11th Division styled Cause No. 25-BCI 1B-0055, Navigation Powder River, LLC

*v. **Phoenix Energy One, LLC *(the ***"Lawsuit") ***regarding the alleged breach of the Parties' Purchase and Sale Agreement;

**WHEREAS, **Plaintiff filed an Amended Petition on March 16, 2026;

**WHEREAS, **Defendant appeared and answered in the Lawsuit, and denied and disputed any and all liability with regard to the claims or damages asserted by Plaintiff;

…